Kevin Caliendo
Stock Analyst at UBS
(4.36)
# 1,098
Out of 4,641 analysts
150
Total ratings
69.44%
Success rate
10.8%
Average return
Main Sectors:
Stocks Rated by Kevin Caliendo
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| CAH Cardinal Health | Maintains: Buy | $125 → $134 | $111.76 | +19.90% | 14 | Oct 22, 2024 | |
| WBA Walgreens Boots Alliance | Maintains: Neutral | $9 → $10 | $9.34 | +7.12% | 14 | Oct 17, 2024 | |
| UNH UnitedHealth Group | Maintains: Buy | $680 → $650 | $567.58 | +14.52% | 11 | Oct 16, 2024 | |
| HUM Humana | Maintains: Neutral | $380 → $250 | $258.70 | -3.36% | 6 | Oct 4, 2024 | |
| LFST LifeStance Health Group | Maintains: Neutral | $9 → $7.5 | $7.27 | +3.23% | 3 | Aug 15, 2024 | |
| HSIC Henry Schein | Maintains: Neutral | $75 → $72 | $70.08 | +2.74% | 4 | Aug 7, 2024 | |
| LH Labcorp Holdings | Maintains: Buy | $260 → $270 | $220.84 | +22.26% | 1 | Aug 2, 2024 | |
| AMWL American Well | Maintains: Neutral | $30 → $12 | $10.10 | +18.76% | 2 | May 23, 2024 | |
| MCK McKesson | Maintains: Buy | $620 → $630 | $503.48 | +25.13% | 13 | May 8, 2024 | |
| CVS CVS Health | Downgrades: Neutral | $85 → $60 | $57.01 | +5.24% | 5 | May 2, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $139 → $146 | $155.78 | -6.28% | 11 | Apr 24, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $280 → $320 | $207.06 | +54.55% | 17 | Apr 15, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $385 → $400 | $316.15 | +26.52% | 10 | Mar 8, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $9 → $8.5 | $10.68 | -20.37% | 5 | Feb 28, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $28 → $26 | $13.25 | +96.23% | 3 | Jan 29, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Neutral | $26 | $18.51 | +40.46% | 1 | Jan 5, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $350 → $380 | $284.30 | +33.66% | 2 | Dec 21, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $72 → $79 | $60.47 | +30.65% | 2 | Dec 21, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $46 | $22.63 | +103.27% | 1 | Oct 16, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $29 → $26 | $19.74 | +31.75% | 1 | Aug 23, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $610 → $575 | $413.40 | +39.09% | 1 | Jul 13, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $185 → $180 | $163.44 | +10.13% | 7 | Jul 21, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $58 → $47 | $23.92 | +96.49% | 8 | Jun 2, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $130 → $72 | $8.86 | +712.64% | 4 | Mar 8, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | $15 → $11 | $18.28 | -39.81% | 4 | May 4, 2021 |
Cardinal Health
Oct 22, 2024
Maintains: Buy
Price Target: $125 → $134
Current: $111.76
Upside: +19.90%
Walgreens Boots Alliance
Oct 17, 2024
Maintains: Neutral
Price Target: $9 → $10
Current: $9.34
Upside: +7.12%
UnitedHealth Group
Oct 16, 2024
Maintains: Buy
Price Target: $680 → $650
Current: $567.58
Upside: +14.52%
Humana
Oct 4, 2024
Maintains: Neutral
Price Target: $380 → $250
Current: $258.70
Upside: -3.36%
LifeStance Health Group
Aug 15, 2024
Maintains: Neutral
Price Target: $9 → $7.5
Current: $7.27
Upside: +3.23%
Henry Schein
Aug 7, 2024
Maintains: Neutral
Price Target: $75 → $72
Current: $70.08
Upside: +2.74%
Labcorp Holdings
Aug 2, 2024
Maintains: Buy
Price Target: $260 → $270
Current: $220.84
Upside: +22.26%
American Well
May 23, 2024
Maintains: Neutral
Price Target: $30 → $12
Current: $10.10
Upside: +18.76%
McKesson
May 8, 2024
Maintains: Buy
Price Target: $620 → $630
Current: $503.48
Upside: +25.13%
CVS Health
May 2, 2024
Downgrades: Neutral
Price Target: $85 → $60
Current: $57.01
Upside: +5.24%
Apr 24, 2024
Maintains: Neutral
Price Target: $139 → $146
Current: $155.78
Upside: -6.28%
Apr 15, 2024
Maintains: Neutral
Price Target: $280 → $320
Current: $207.06
Upside: +54.55%
Mar 8, 2024
Maintains: Buy
Price Target: $385 → $400
Current: $316.15
Upside: +26.52%
Feb 28, 2024
Maintains: Neutral
Price Target: $9 → $8.5
Current: $10.68
Upside: -20.37%
Jan 29, 2024
Maintains: Buy
Price Target: $28 → $26
Current: $13.25
Upside: +96.23%
Jan 5, 2024
Initiates: Neutral
Price Target: $26
Current: $18.51
Upside: +40.46%
Dec 21, 2023
Maintains: Neutral
Price Target: $350 → $380
Current: $284.30
Upside: +33.66%
Dec 21, 2023
Maintains: Neutral
Price Target: $72 → $79
Current: $60.47
Upside: +30.65%
Oct 16, 2023
Initiates: Buy
Price Target: $46
Current: $22.63
Upside: +103.27%
Aug 23, 2023
Maintains: Neutral
Price Target: $29 → $26
Current: $19.74
Upside: +31.75%
Jul 13, 2023
Maintains: Buy
Price Target: $610 → $575
Current: $413.40
Upside: +39.09%
Jul 21, 2022
Maintains: Neutral
Price Target: $185 → $180
Current: $163.44
Upside: +10.13%
Jun 2, 2022
Upgrades: Buy
Price Target: $58 → $47
Current: $23.92
Upside: +96.49%
Mar 8, 2022
Maintains: Neutral
Price Target: $130 → $72
Current: $8.86
Upside: +712.64%
May 4, 2021
Downgrades: Neutral
Price Target: $15 → $11
Current: $18.28
Upside: -39.81%